Search Within

Mark Kris

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (28)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (73)
  2. Sloan Kettering Institute Postdocs (73)
  3. Solid Tumor Oncology Division (73)
  4. Thoracic Oncology (73)
  5. Department of Pathology and Laboratory Medicine (63)
  6. GSK Faculty (61)

More Groups

People
  1. Gregory Riely (45)
  2. Marc Ladanyi (44)
  3. Charles Rudin (36)
  4. Alexander Drilon (30)
  5. Helena Yu (30)
  6. Maria Arcila (30)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (12)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (14)
  3. Journal of Thoracic Oncology (14)
  4. Annals of Oncology (3)
  5. Cancer Discovery (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (5)
  5. Oxford University Press (4)
  6. Mosby Elsevier (2)

More Publishers

Results (73)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
    Meeting Abstract

    Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Importance of distinguishing adenocarcinoma and squamous cell carcinoma in assessment of pathologic response after neoadjuvant chemotherapy
    Meeting Abstract

    Emoto, K.; Qu, Y.; Zheng, H.; Aly, R.; Eguchi, T.; Chaft, J.; Tan, K. S.; Kris, M.; Adusumilli, P.; Travis, W.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Importance of distinguishing adenocarcinoma and squamous cell carcinoma in assessment of pathologic response after neoadjuvant chemotherapy
    Meeting Abstract

    Emoto, K.; Qu, Y.; Zheng, H.; Aly, R.; Eguchi, T.; Chaft, J.; Tan, K. S.; Kris, M.; Adusumilli, P.; Travis, W.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Adrenal metastasectomy in the presence and absence of extraadrenal metastatic disease
    Journal Article

    Russo, A. E.; Untch, B. R.; Kris, M. G.; Chou, J. F.; Capanu, M.; Coit, D. G.; Chaft, J. E.; D'Angelica, M. I.; Brennan, M. F.; Strong, V. E.
    Annals of Surgery (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save